In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Remote patient monitoring

This article was originally published in The Gray Sheet

Executive Summary

Remote "in-home" patient monitoring is a "disruptive" technological innovation that could save the U.S. health care system up to $400 billion a year by increasing medication adherence, reducing avoidable post-acute complications and improving self-care management of chronic conditions, according to a 1new report from Deloitte LLP's Center for Health Solutions. The study cites an online survey of 3,000 adults that found about three-quarters of consumers, especially women and seniors, want more in-home monitoring devices and internet-based methods of managing their health care. A quarter said they would be willing to pay more to physicians for online access to records, e-mail access and same-day appointments

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel